Figure 2.
Simulated serum profiles for typical SLE patient receiving belimumab IV 10 mg/kg every four weeks (red line) vs SC 200 mg weekly (green line). The dashed line represents the belimumab IV steady-state trough concentration.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.